.Merck trumps earnings expectations, increases sales overview on solid need for top medications like Keytruda CNBCMerck & Co. (MRK US) Trumps Income Projections as Keytruda Sales Increase BloombergMerck Stock: Pharma Giant Posts Powerful End Results, Yet Expectation Drops Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats profit and purchases requirements among Keytruda asset, yet supplies blended full-year expectation MarketWatch.